| Literature DB >> 28930004 |
Moataz Abd El Ghany, Mona Alsomali, Malak Almasri, Eriko Padron Regalado, Raeece Naeem, AbdulHafeez Tukestani, Abdullah Asiri, Grant A Hill-Cawthorne, Arnab Pain, Ziad A Memish.
Abstract
Hajj, the annual Muslim pilgrimage to Mecca, Saudi Arabia, is a unique mass gathering event that raises public health concerns in the host country and globally. Although gastroenteritis and diarrhea are common among Hajj pilgrims, the microbial etiologies of these infections are unknown. We collected 544 fecal samples from pilgrims with medically attended diarrheal illness from 40 countries during the 2011-2013 Hajj seasons and screened the samples for 16 pathogens commonly associated with diarrheal infections. Bacteria were the main agents detected, in 82.9% of the 228 positive samples, followed by viral (6.1%) and parasitic (5.3%) agents. Salmonella spp., Shigella/enteroinvasive Escherichia coli, and enterotoxigenic E. coli were the main pathogens associated with severe symptoms. We identified genes associated with resistance to third-generation cephalosporins ≈40% of Salmonella- and E. coli-positive samples. Hajj-associated foodborne infections pose a major public health risk through the emergence and transmission of antimicrobial drug-resistant bacteria.Entities:
Keywords: Hajj; Saudi Arabia; antimicrobial resistance; bacteria; diarrhea; enteric infections; mass gathering; viruses
Mesh:
Year: 2017 PMID: 28930004 PMCID: PMC5621540 DOI: 10.3201/eid2310.161642
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Demographic characteristics of persons who acquired enteric infections during their travel for Hajj, 2011–2013
| Characteristic | Year | Total | Statistical analyses* | |||
|---|---|---|---|---|---|---|
| 2011 | 2012 | 2013 | χ2 | p value | ||
| No. patients | 118 | 297 | 129 | 544 | ||
| Median patient age, y (quartile deviation) | 40 ( | 40 ( | 40.5 ( | 40.17 ( | ||
| No. countries of origin represented | 20 | 30 | 20 | 40 | | |
| Sex, no. (%) | ||||||
| F | 32 (27.12) | 84 (28.28) | 30 (23.26) | 146 (26.84) | 1.07 | 0.59 |
| M | 86 (72.12) | 213 (71.72) | 98 (75.97) | 397 (72.98) | ||
*Comparison between Hajj seasons.
Clinical characteristics of persons who acquired enteric infections during their travel for Hajj, 2011–2013
| Characteristic | Year | Total | Statistical analyses* | |||
|---|---|---|---|---|---|---|
| 2011 | 2012 | 2013 | χ2 | p value | ||
| Hospitalization, no. (%) | ||||||
| Outpatient | 94 (79.66) | 263 (88.55) | 116 (89.92) | 473 (86.95) | 7.54 | 0.02 |
| Inpatient | 24 (20.34) | 33 (11.11) | 13 (10.08) | 70 (12.87) | ||
| Not defined | 0 | 1 (0.34) | 0 | 1 (0.18) | | |
| Stool consistency, no. (%) | ||||||
| Unformed† | 57 (48.31) | 187 (62.96) | 76 (58.91) | 320 (58.82) | 9.19 | 0.01 |
| Watery‡ | 60 (50.85) | 101 (34.01) | 48 (37.12) | 209 (38.42) | ||
| Not defined | 1 (0.85) | 9 (3.03) | 5 (3.88) | 15 (2.76) | | |
| Abdominal pain/cramp, no. (%) | ||||||
| Yes | 106 (89.83) | 282 (94.95) | 103 (79.84) | 491 (90.26) | ||
| No | 0 | 0 | 0 | 0 | ||
| Not defined | 12 (10.17) | 15 (5.05) | 26 (20.16) | 53 (9.74) | | |
| Bowel movements/d, no. (%) | ||||||
| <3 | 9 (7.63) | 5 (1.68) | 3 (2.33) | 17 (3.13) | 11.21 | 0.02 |
| 3–5 | 78 (66.1) | 212 (71.38) | 76 (58.91) | 366 (67.28) | ||
| >5 | 19 (16.1) | 65 (21.89) | 24 (18.6) | 108 (19.85) | ||
| Not defined | 12 (10.17) | 15 (5.05) | 26 (20.16) | 53 (9.74) | | |
| Duration of diarrhea, d, no. (%) | ||||||
|
| 61 (51.69) | 140 (47.14) | 67 (51.94) | 268 (49.26) | 2.99 | 0.56 |
| 3–5 | 42 (35.59) | 119 (40.07) | 42 (32.56) | 203 (37.32) | ||
| >5 | 12 (10.17) | 24 (8.08) | 8 (6.2) | 44 (8.09) | ||
| Not defined | 3 (2.54) | 14 (4.71) | 12 (9.3) | 29 (5.33) | | |
| Presence of mucus, no. (%) | ||||||
| Yes | 38 (32.2) | 165 (55.56) | 41 (31.78) | 244 (44.85) | 32.08 | <0.001 |
| No | 80 (67.8) | 126 (42.42) | 86 (66.67) | 292 (53.68) | ||
| Not defined | 0 | 6 (2.02) | 2 (1.55) | 8 (1.47) | | |
| Presence of blood, no. (%) | ||||||
| Yes | 14 (11.86) | 26 (8.75) | 11 (8.53) | 51 (9.38) | 0.98 | 0.61 |
| No | 104 (88.14) | 265 (89.23) | 116 (89.92) | 485 (89.15) | ||
| Not defined | 0 | 6 (2.02) | 2 (1.55) | 8 (1.47) | | |
| Vomiting, no. (%) | ||||||
| Yes | 33 (27.97) | 80 (26.94) | 12 (9.3) | 125 (22.98) | 17.92 | <0.001 |
| No | 85 (72.03) | 211 (71.04) | 115 (89.15) | 411 (75.55) | ||
| Not defined | 0 | 6 (2.02) | 2 (1.55) | 8 (1.47) | | |
| Fever, no. (%)§ | ||||||
| No fever | 87 (73.73) | 167 (56.23) | 103 (79.84) | 357 (65.63) | 26.90 | <0.001 |
| Moderate | 23 (19.49) | 72 (24.24) | 25 (19.34) | 120 (22.06) | ||
| Severe | 3 (2.54) | 32 (10.77) | 1 (0.78) | 36 (6.62) | ||
| Not defined | 5 (4.24) | 26 (8.75) | 0 | 31 (5.7) | | |
| Dehydration, no. (%)¶ | ||||||
| Yes | 42 (35.59) | 53 (17.85) | 39 (30.23) | 134 (24.63) | 16.89 | <0.001 |
| No | 76 (64.41) | 238 (80.13) | 85 (65.89) | 399 (73.35) | ||
| Not defined | 0 | 6 (2.02) | 5 (3.88) | 11 (2.02) | ||
*Comparison between Hajj seasons. †Bristol 6. ‡Bristol 7. §Moderate fever defined as >37.5°C and <39.0°C; severe fever defined as >39.0°C. ¶Dehydration defined as >2 of the following signs or symptoms: thirst, dry mouth, weakness/light headedness, and darkening of the urine/decrease in urination.
Characteristics of etiologic agents associated with enteric infections among persons infected during their travel for Hajj, 2011–2013*
| Characteristic | Year | Total | ||
|---|---|---|---|---|
| 2011 | 2012 | 2013 | ||
| No. screened samples | 118 | 297 | 129 | 544 |
| Samples positive for agent, no. (%) | 51 (43.22) | 120 (40.40) | 57 (44.19) | 228 (41.91) |
| Bacterial agents, no. (%) | 41 (34.75) | 96 (32.32) | 52 (40.31) | 189 (34.74) |
|
| 13 (11.02) | 25 (8.42) | 24 (18.6) | 62 (11.4) |
|
| 5 (4.24) | 28 (9.43) | 8 (6.2) | 41 (7.54) |
| ETEC | 12 (10.17) | 29 (9.76) | 7 (5.43) | 48 (8.82) |
| EPEC | 3 (2.54) | 5 (1.68) | 8 (6.2) | 16 (2.94) |
| EHEC | 2 (1.69) | 2 (0.67) | 0 | 4 (0.74) |
| DAEC | 3 (2.54) | 1 (0.34) | 3 (2.33) | 7 (1.29) |
| EAEC | 3 (2.54) | 2 (0.67) | 2 (1.55) | 7 (1.29) |
|
| 0 | 4 (1.35) | 0 | 4 (0.74) |
| Viral agents, no. (%) | 6 (5.08) | 7 (2.36) | 1 (0.78) | 14 (2.57) |
| Astrovirus | 0 | 2 (0.67) | 1 (0.78) | 3 (0.55) |
| Norovirus | 2 (1.69) | 2 (0.67) | 0 | 4 (0.74) |
| Rotavirus | 4 (3.39) | 2 (0.67) | 0 | 6 (1.1) |
| Adenovirus | 0 | 1 (0.34) | 0 | 1 (0.18) |
| Parasitic agents, no. (%) | 3 (2.54) | 8 (2.69) | 1 (0.78) | 12 (2.21) |
|
| 3 (2.54) | 6 (2.02) | 1 (0.78) | 10 (1.84) |
|
| 0 | 2 (0.67) | 0 | 2 (0.37) |
| Mixed infectious agents, no. (%) | 1 (0.85) | 9 (3.03) | 3 (2.33) | 13 (2.39) |
| Bacteria and virus | 0 | 5 (1.68)† | 1 (0.78)‡ | 6 (1.1) |
| Bacteria and parasite | 1 (0.85)§ | 4 (1.35)¶ | 1 (0.78)# | 6 (1.1) |
| Bacteria, virus, and parasite | 0 | 0 | 1 (0.78)** | 1 (0.18) |
*EAEC, enteroaggregative Escherichia coli; EHEC, enterohemorrhagic E. coli; EIEC, enteroinvasive E. coli; EPEC, enteropathogenic E. coli; ETEC, enterotoxigenic E. coli; DAEC, diffusely adherent E. coli. †Salmonella and rotavirus G1P[8], Shigella/EIEC and astrovirus HAstV2, ETEC and astrovirus HAstV2, Salmonella and adenovirus, and EPEC and rotavirus G1P[8]. ‡EPEC and adenovirus. §Salmonella and Giardia. ¶EPEC and Giardia, EAEC and Giardia, ETEC and Giardia, and Salmonella and Giardia. #EPEC and Cryptosporidium. **EPEC, adenovirus, and Giardia.
Relationship between severity of diarrheal disease and identified etiologic agents among persons who acquired enteric infections during their travel for Hajj, 2011–2013*
| Category | Severity of diarrheal disease | Statistical analyses | |||
|---|---|---|---|---|---|
| Severe | Mild | χ2 | p value | ||
| Total no. cases | 412 | 132 | |||
| Positive for etiologic agent, no. (%) | 185 (44.9) | 43 (32.58) |
| 6.24† | 0.01 |
| Bacterial agents, no. (%) | 153 (37.14) | 36 (27.27) | 4.29‡ | 0.04 | |
|
| 45 (10.92) | 17 (12.88) | 4.19§ | 0.04 | |
|
| 35 (8.5) | 6 (4.55) | |||
| ETEC | 43 (10.44) | 5 (3.79) | 5.49¶ | 0.019 | |
| EPEC | 13 (3.16) | 3 (2.27) | |||
| EHEC | 3 (0.73) | 1 (0.76) | |||
| DAEC | 7 (1.7) | 0 | |||
| EAEC | 5 (1.21) | 2 (1.52) | |||
|
| 2 (0.49) | 2 (1.52) |
| | |
| Viral agents, no. (%) | 13 (3.16) | 1 (0.76) | 2.29 | 0.13 | |
| Astrovirus | 2 (0.49) | 1 (0.76) | |||
| Norovirus | 4 (0.97) | 0 | |||
| Rotavirus | 6 (1.46) | 0 | |||
| Adenovirus | 1 (0.24) | 0 |
| | |
| Parasitic agents, no. (%) | 10 (2.43) | 2 (1.52) | 0.39 | 0.53 | |
|
| 8 (1.94) | 2 (1.52) | |||
|
| 2 (0.49) | 0 |
| | |
| Mixed infectious agents, no. (%) | 9 (2.18) | 4 (3.03) | 0.31 | 0.58 | |
| Bacteria and virus | 4 (0.97) | 2 (1.52) | |||
| Bacteria and parasite | 5 (1.21) | 1 (0.76) | |||
| Bacteria, virus, and parasite | 0 | 1 (0.76) | |||
*EAEC, enteroaggregative Escherichia coli; EHEC, enterohemorrhagic E. coli; EIEC, enteroinvasive E. coli; EPEC, enteropathogenic E. coli; ETEC, enterotoxigenic E. coli; DAEC, diffusely adherent E. coli; OR, odds ratio. †Compared with total number of cases. OR 1.69, p=0.01. ‡Compared with total number of cases. OR 1.58, p=0.04. §Compared with total number of positive bacteria. OR 0.47, p=0.04. ¶Compared with total number of cases. OR 2.96, p=0.02.
FigureDistribution of infectious agents among persons who acquired enteric infections during their travel for Hajj, 2011–2013, by age group. A) Identified versus unidentified samples; B) type of pathogen; C) bacterial agent. Bacterial agents were the most predominant pathogen detected among all age groups. NI, age not identified.
Distribution of β-lactamase genes among the identified bacterial agents among persons who acquired enteric infections during their travel for Hajj, 2011–2013*
| Year/bacteria | β-lactamase genes | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| 2011 |
|
|
|
|
|
|
|
|
| 3+2† | 2† | 0 | 0 | 0 | 0 | |
|
| 1+1† | 1† | 0 | 0 | 0 | 0 | |
| ETEC | 3+4† | 4† | 0 | 0 | 0 | 0 | |
| EAEC | 3 | 0 | 0 | 0 | 0 | 0 | |
| EHEC | 2 | 0 | 0 | 0 | 0 | 0 | |
| DAEC | 0 | 1 | 0 | 0 | 0 | 0 | |
| 2012 | |||||||
|
| 6 | 3 | 0 | 0 | 0 | 0 | |
|
| 4 | 0 | 0 | 0 | 0 | 0 | |
| ETEC | 5+1† | 1† | 0 | 0 | 0 | 0 | |
| EPEC | 1 | 0 | 0 | 0 | 0 | 0 | |
| EHEC | 2 | 0 | 0 | 0 | 0 | 0 | |
|
| 2+1† | 1† | 0 | 0 | 0 | 0 | |
| 2013 | |||||||
|
| 10+1† | 1† | 0 | 0 | 0 | 0 | |
|
| 3 | 0 | 0 | 0 | 0 | 0 | |
| ETEC | 2+1† | 1† | 0 | 0 | 0 | 0 | |
| EPEC | 6+1† | 1† | 0 | 0 | 0 | 0 | |
| EAEC | 1 | 0 | 0 | 0 | 0 | 0 | |
*EAEC, enteroaggregative Escherichia coli; EHEC, enterohemorrhagic E. coli; EIEC, enteroinvasive E. coli; EPEC, enteropathogenic E. coli; ETEC, enterotoxigenic E. coli; DAEC, diffusely adherent E. coli. †Multidrug-resistant; both blaCTX-M-15 and blaNDM were detected.